par Louvet, Alexandre;Diaz, Emmanuel;Dharancy, Sébastien;Coevoet, Hugues;Texier, Frédéric;Thévenot, Thierry;Deltenre, Pierre
;Canva, Valérie;Plane, Christophe;Mathurin, Philippe
Référence Journal of hepatology, 48, 3, page (465-470)
Publication Publié, 2008-03
;Canva, Valérie;Plane, Christophe;Mathurin, PhilippeRéférence Journal of hepatology, 48, 3, page (465-470)
Publication Publié, 2008-03
Article révisé par les pairs
| Résumé : | In severe alcoholic hepatitis (AH), 40% of patients will obtain no benefit from corticosteroids. Improvement in management of non-responders is warranted and only pentoxifylline can be considered an alternative. A two-step strategy was evaluated consisting of early withdrawal of corticosteroids and a switch to pentoxifylline for 28 additional days in non-responders identified using early change in bilirubin level. |



